Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses

Table 1 Comparison of SF-36 items in patients with SSc and those with other dermatoses

	Number of patients	Mean age (years)	Median disease duration (years)	Physical function	Role physical	Bodily pain	General health	Vitality	Social function	Role emotional	Mental health
Our SSc patients	41	58 ± 13	8 (2 – 40)	66 ± 27	66 ± 43	59 ± 26	54 ± 24	54 ± 23	77 ± 25	73 ± 42	72 ± 17
Better or similar in all dimensions
Normal population without chronic disease [14]				97	97	95	80	72	95	97	80
Patients with occupational contact dermatitis [15]	109	41	2.7	95	100	82	72	65	88	100	80
Patients with ichthyosis [16]	121	44.8		95	100	84	77	60	100	100	80
Patients with non-melanoma cervicofacial skin cancer [17]	121	63^a		85	78	81	74	65	86	84	76
Patients with contact eczema [18]	38			95	100	63	72	58	88	100	70
Patients with atopic eczema [19]	70			88	76	74	65	61	83	78	75
Poorer only in mental health
Patients with nail disorders ( >1a) [20]	72			88	76	77	65	64	77	67	65
Patients with vitiligo in China [21]	101	30.8	6.8	89	68	80	65	68	76	65	61
Health care workers with work-related skin diseases [22]	278	36.9	6.2	90	77	65	63	54	81	80	66
Chronic skin diseases [14]				80	71	69	57	54	80	74	65
Poorer in social function and mental health
Patients with atopic dermatitis [23]	66	34.2	20.2	81	56	74	62	54	67	57	51
Patients with different types of psoriasis < 10 years [24]	380	44.3	12.4	81	62	65	64	59	62	56	58
Psoriasis ≥ 10 years [24]				77	62	60	58	56	59	54	56
Poorer or similar in all dimensions
Patients with pemphigus vulgaris [25]	58			72	43	63	49	49	61	47	53
Patients with systemic lupus erythematosus [26]	90	40.5	10.4	50	37	54	41	41	61	56	62

ISSN: 1756-0500